𝔖 Bobbio Scriptorium
✦   LIBER   ✦

201Tolerability and efficacy of interferon-ribavirin therapy for recurrent hepatitis C

✍ Scribed by SHEINER, P; BUSITTIL, A; MATSUMOTO, C; KIMSCHLUGER, L; EMRE, S; FISHBEIN, T; FACCIULO, M; SCHWARTZ, M; MILLER, C

Book ID
123197197
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
116 KB
Volume
6
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical and histological efficacy of pe
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation
✍ Inmaculada FernΓ‘ndez; Juan Carlos Meneu; Francisco Colina; Ignacio GarcΓ­a; Raque πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

Treatment of recurrent hepatitis C in liver transplant is controversial. The aim of our study was to evaluate the clinical and histological efficacy of pegylated interferon alpha 2b (PEG-IFN) and ribavirin therapy of recurrent hepatitis C after liver transplantation (LT). We prospectively included 4

Therapy of hepatitis C: Alpha interferon
Therapy of hepatitis C: Alpha interferon and ribavirin
✍ O Reichard; R Schvarcz; O Weiland πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 2 views

Ribavirin is a nucleoside analogue that has been evaluated as a therapy of chronic hepatitis C alone and in combination with alpha interferon. Ribavirin is well absorbed orally and is typically given in doses of 1,000 to 1,200 mg/d. Three randomized, placebo-controlled studies comprising more than 1